BEAMER Project

BEAMER is the latest Innovative Medicines Initiative international consortium to address the emerging challenge of patient adherence to prescribed treatments.

Each year, this health issue contributes to approximately 200,000 premature deaths in the European Union and an estimated €125 billion in avoidable hospitalisations, emergency care and adult outpatient visits—but hope for real change is here.

With the support of the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA), 28 public and private European partners from academia, civil society and industry will embark on a 5-year undertaking to impact physicians and patients’ lives for the better.